Meningitis B patients have been offered new hope after trials showed the potential of a new vaccine to protect against majority of the diverse strains of the disease.
Trials showed that antibodies induced by 4CMenB killed nearly 80% of 1,000 strains of the disease from across Europe.
The jab was found to offer protection when used alone or with vaccines for other strains of meningitis B in children.
It was also found to be effective in combating the disease when given as a booster jab for toddlers.
Steve Dayman, Chief Executive of the charity Meningitis UK, said: "This data is a very positive step in the fight to eradicate meningitis B, which is the biggest killer of all types of meningitis in the UK.
"This vaccine is the first of its kind and has the potential to save thousands of lives."
Meningitis B is the most common form of bacterial meningitis in the UK and is also one of the most deadly, in some cases killing babies and toddlers in less than four hours.